Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 12,580
-210 (-1.64%)
At close: Nov 14, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 151.2 billion as of November 14, 2025. Its market cap has decreased by -15.57% in one year.
Market Cap
151.20B
Enterprise Value
218.97B
Revenue
14.33B
Ranking
n/a
PE Ratio
33.98
Stock Price
12,580.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 151.20B, a decrease of -58.07%. That is a compound annual growth rate of -17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 151.20B | -16.74% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
| May 28, 2021 | 360.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 43.20T |
| ALTEOGEN | 29.63T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.60T |
| Yuhan | 9.35T |
| Peptron | 7.22T |
| HLB Co., Ltd. | 6.50T |